According to Roche's latest financial reports the company's total assets are $107.60 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $107.60 B | 12.76% |
2022-12-31 | $95.42 B | -5.56% |
2021-12-31 | $101.03 B | 3.41% |
2020-12-31 | $97.70 B | 13.9% |
2019-12-31 | $85.78 B | 7.46% |
2018-12-31 | $79.82 B | 1.37% |
2017-12-31 | $78.74 B | 4.42% |
2016-12-31 | $75.40 B | -1.66% |
2015-12-31 | $76.68 B | 0.35% |
2014-12-31 | $76.41 B | 9.05% |
2013-12-31 | $70.07 B | -1.33% |
2012-12-31 | $71.01 B | 8.18% |
2011-12-31 | $65.64 B | 0.53% |
2010-12-31 | $65.29 B | -9.43% |
2009-12-31 | $72.09 B | -1.18% |
2008-12-31 | $72.95 B | 5.39% |
2007-12-31 | $69.22 B | 13.18% |
2006-12-31 | $61.16 B | 16.31% |
2005-12-31 | $52.58 B | 2.62% |
2004-12-31 | $51.24 B | 6.53% |
2003-12-31 | $48.10 B | -31.89% |
2002-12-31 | $70.63 B | -15% |
2001-12-31 | $83.09 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 59.82% | ๐บ๐ธ USA |
Novartis NVS | $94.33 B | -12.33% | ๐จ๐ญ Switzerland |
Pfizer PFE | $226.50 B | 110.50% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | -31.96% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | -9.71% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 29.94% | ๐ซ๐ท France |
Becton Dickinson BDX | $52.27 B | -51.42% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | -0.86% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $73.94 B | -31.28% | ๐ฌ๐ง UK |